Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

1.

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.

Kotulska K, Borkowska J, Mandera M, Roszkowski M, Jurkiewicz E, Grajkowska W, Bilska M, Jóźwiak S.

Childs Nerv Syst. 2014 Dec;30(12):2037-42. doi: 10.1007/s00381-014-2555-8. Epub 2014 Sep 17.

2.

Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis.

Ford N, Shubber Z, Jao J, Abrams EJ, Frigati L, Mofenson L.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):512-21. doi: 10.1097/QAI.0000000000000211. Review.

3.

Fetal safety of macrolides.

Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, Levy A.

Antimicrob Agents Chemother. 2013 Jul;57(7):3307-11. doi: 10.1128/AAC.01691-12. Epub 2013 May 6.

4.

Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L'ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H.

J Clin Microbiol. 2013 Jul;51(7):2103-11. doi: 10.1128/JCM.00169-13. Epub 2013 Apr 24.

5.

Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy.

Taylor AW, Mosimaneotsile B, Mathebula U, Mathoma A, Moathlodi R, Theebetsile I, Samandari T.

Infect Dis Obstet Gynecol. 2013;2013:195637. doi: 10.1155/2013/195637. Epub 2013 Mar 7.

6.

Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study.

Andersen JT, Petersen M, Jimenez-Solem E, Broedbaek K, Andersen NL, Torp-Pedersen C, Keiding N, Poulsen HE.

PLoS One. 2013;8(1):e53327. doi: 10.1371/journal.pone.0053327. Epub 2013 Jan 2.

7.

Safety of macrolides during pregnancy.

Lin KJ, Mitchell AA, Yau WP, Louik C, Hernández-Díaz S.

Am J Obstet Gynecol. 2013 Mar;208(3):221.e1-8. doi: 10.1016/j.ajog.2012.12.023. Epub 2012 Dec 16.

8.

Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 mice.

Tsai PT, Greene-Colozzi E, Goto J, Anderl S, Kwiatkowski DJ, Sahin M.

Behav Genet. 2013 Jan;43(1):51-9. doi: 10.1007/s10519-012-9571-9. Epub 2012 Dec 12.

9.

The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals.

Lachmann PJ.

QJM. 2012 Dec;105(12):1179-89. doi: 10.1093/qjmed/hcs148. Epub 2012 Aug 20.

10.

Maternal exposure to amoxicillin and the risk of oral clefts.

Lin KJ, Mitchell AA, Yau WP, Louik C, Hernández-Díaz S.

Epidemiology. 2012 Sep;23(5):699-705. doi: 10.1097/EDE.0b013e318258cb05.

11.

Assessing the risk of birth defects associated with exposure to fixed-dose combined antituberculous agents during pregnancy in rats.

Awodele O, Patrick EB, Oluwatoyin Agbaje E, Oremosu AA, Gbotolorun SC.

ScientificWorldJournal. 2012;2012:585094. doi: 10.1100/2012/585094. Epub 2012 May 3.

12.

Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway.

Romøren M, Lindbæk M, Nordeng H.

Br J Clin Pharmacol. 2012 Dec;74(6):1053-62. doi: 10.1111/j.1365-2125.2012.04286.x.

13.

Drug certainty-response in interview-based studies.

Yau WP, Lin KJ, Werler MM, Louik C, Mitchell AA, Hernández-Díaz S.

Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1210-6. doi: 10.1002/pds.2234. Epub 2011 Sep 13.

14.

Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex.

Anderl S, Freeland M, Kwiatkowski DJ, Goto J.

Hum Mol Genet. 2011 Dec 1;20(23):4597-604. doi: 10.1093/hmg/ddr393. Epub 2011 Sep 1.

15.

What can we learn from the thalidomide experience: an ophthalmologic perspective.

Miller MT, Strömland KK.

Curr Opin Ophthalmol. 2011 Sep;22(5):356-64. doi: 10.1097/ICU.0b013e3283499f24. Review.

16.

Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil.

Vianna FS, Lopez-Camelo JS, Leite JC, Sanseverino MT, Dutra Mda G, Castilla EE, Schüler-Faccini L.

PLoS One. 2011;6(7):e21735. doi: 10.1371/journal.pone.0021735. Epub 2011 Jul 6.

17.

Signaling by FGFR2b controls the regenerative capacity of adult mouse incisors.

Parsa S, Kuremoto K, Seidel K, Tabatabai R, Mackenzie B, Yamaza T, Akiyama K, Branch J, Koh CJ, Al Alam D, Klein OD, Bellusci S.

Development. 2010 Nov;137(22):3743-52. doi: 10.1242/dev.051672.

18.

Congenital aberrant tearing: a re-look.

Miller MT, Strömland K, Ventura L.

Trans Am Ophthalmol Soc. 2008;106:100-15; discussion 115-6. Review.

19.

Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.

Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer SM, Gideon PS, Hall KS, Kaltenbach LA, Ray WA.

Paediatr Perinat Epidemiol. 2009 Jan;23(1):18-28. doi: 10.1111/j.1365-3016.2008.00978.x.

20.

Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations.

Hallene KL, Oby E, Lee BJ, Santaguida S, Bassanini S, Cipolla M, Marchi N, Hossain M, Battaglia G, Janigro D.

Neuroscience. 2006 Sep 29;142(1):267-83. Epub 2006 Jul 20. Erratum in: Neuroscience. 2009 Dec 15;164(3):1387.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk